Theraclion S.A.
TCLIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -54.5% | 47.5% | -16.6% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -865.4% | -59.3% | -246.9% | -306.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -838.6% | -246.3% | -495.8% | -297.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -693.6% | -201.7% | -401.8% | -253.9% |
| EPS Diluted | -0.12 | -0.076 | -0.17 | -0.17 |
| % Growth | -57.7% | 55.2% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |